← Back to headlines
Cathie Wood Buys Dip in CRISPR Therapeutics
Investor Cathie Wood has reportedly bought the dip in gene-editing firm CRISPR Therapeutics, indicating confidence in the company's future despite recent market movements.
11 Mar, 10:00 — 11 Mar, 10:00
Sources
Showing 1 of 1 sources
Related Stories
Honda Orders $9 Billion Supplier Cost Cuts to Counter Chinese EV Rivals
36m ago
US-Iran Conflict Intensifies with Retaliatory Strikes and Rising Energy Prices
39m ago
Apple Appoints John Ternus as CEO Amid Leadership Transition and Strategic Shift
41m ago
Nestlé to Sell Vitamins Business to Financial Investor for $1 Billion
56m ago